53349 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 12
00:54 UTC
|
IHP
IntegraFin
|
◎ Target | firm only | Buy | GBX 475→ GBX 490+3.2% |
|
Aug 12
00:54 UTC
|
IDXX
IDEXX Laboratories
|
◎ Target | Glen Santangelo ★★★☆☆ #1082 | Overweight | $800.00→ $710.00-11.2% |
|
Aug 12
00:54 UTC
|
HST
Host Hotels & Resorts
|
◎ Target | Jay Kornreich ★★★★☆ #895 | Neutral | $23.00→ $24.00+4.3% |
|
Aug 12
00:54 UTC
|
HQI
HireQuest
|
◎ Target | Michael Baker ★★★★☆ #516 | Buy | $15.00→ $19.00+26.7% |
|
Aug 12
00:54 UTC
|
HLT
Hilton Worldwide
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1064 | Neutral | $353.00→ $345.00-2.3% |
|
Aug 12
00:54 UTC
|
HLN
Haleon
|
◎ Target | firm only | Sec→ r perform | GBX 370→ GBX 390+5.4% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Jonna Kim ★★★★★ #287 | Hold | $25.00→ $30.00+20.0% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | George Hill ★★★★☆ #687 | Hold | $25.00→ $26.00+4.0% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Craig Hettenbach ★★★★★ #292 | Equal Weight | $21.00→ $28.00+33.3% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Daniel Grosslight ★★★☆☆ #1225 | Neutral | $35.00→ $33.00-5.7% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Allen Lutz ★★★★☆ #774 | Neutral | $30.00→ $32.00+6.7% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Ryan MacDonald ★★★★☆ #538 | Buy | $35.00→ $42.00+20.0% |
|
Aug 12
00:54 UTC
|
HIK
Hikma Pharmaceuticals
|
◎ Target | firm only | Buy | GBX 1,800→ GBX 2,100+16.7% |
|
Aug 12
00:54 UTC
|
HGTY
Hagerty
|
◎ Target | Thomas McJoynt-Griffith not yet tracked | Outperform | $15.00→ $16.00+6.7% |
|
Aug 12
00:54 UTC
|
HE
Hawaiian Electric Industries
|
◎ Target | Nicholas Campanella ★★★☆☆ #1410 | Equal Weight | $13.00→ $12.00-7.7% |
|
Aug 12
00:54 UTC
|
HD
Home Depot
|
◎ Target | Zachary Fadem ★★★☆☆ #1200 | Overweight | $360.00→ $400.00+11.1% |
|
Aug 12
00:54 UTC
|
HCAT
Health Catalyst
|
◎ Target | Daniel Grosslight ★★★☆☆ #1225 | Neutral | $2.50→ $2.00-20.0% |
|
Aug 12
00:54 UTC
|
HBT
HBT Financial
|
◎ Target | Jeff Rulis ★★★★★ #167 | Neutral | $36.00→ $38.00+5.6% |
|
Aug 12
00:54 UTC
|
H
Hyatt Hotels
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1064 | Neutral | $180.00→ $185.00+2.8% |
|
Aug 12
00:54 UTC
|
GWW
W.W. Grainger
|
◎ Target | Guy Hardwick ★★★★☆ #490 | Underweight | $1,166.00→ $1,185.00+1.6% |
|
Aug 12
00:54 UTC
|
GDRX
GoodRx
|
◎ Target | Charles Rhyee ★★★★☆ #390 | Buy | $4.00→ $5.00+25.0% |
|
Aug 12
00:54 UTC
|
GDRX
GoodRx
|
◎ Target | Daniel Grosslight ★★★☆☆ #1225 | Buy | $4.00→ $5.00+25.0% |
|
Aug 12
00:54 UTC
|
GCMG
GCM Grosvenor
|
◎ Target | Crispin Love ★★★☆☆ #1224 | Overweight | $15.00→ $16.00+6.7% |
|
Aug 12
00:54 UTC
|
GCMG
GCM Grosvenor
|
◎ Target | Kenneth Worthington not yet tracked | Neutral | $12.00→ $13.00+8.3% |
|
Aug 12
00:54 UTC
|
FUN
Six Flags Entertainment
|
◎ Target | Matthew Boss ★★★☆☆ #1215 | Neutral | $26.00→ $22.00-15.4% |
|
Aug 12
00:54 UTC
|
FIVE
Five Below
|
◎ Target | David Bellinger ★★★☆☆ #976 | Outperform | $220.00→ $260.00+18.2% |
|
Aug 12
00:54 UTC
|
FERG
Ferguson
|
◎ Target | Sam Reid ★★★☆☆ #1378 | Overweight | $285.00→ $295.00+3.5% |
|
Aug 12
00:54 UTC
|
FERG
Ferguson
|
◎ Target | David Manthey ★★★☆☆ #1617 | Outperform | $285.00→ $288.00+1.1% |
|
Aug 12
00:54 UTC
|
FERG
Ferguson
|
◎ Target | Scott Schneeberger ★★★☆☆ #1758 | Outperform | $280.00→ $288.00+2.9% |
|
Aug 12
00:54 UTC
|
FERG
Ferguson
|
◎ Target | Mike Dahl not yet tracked | Outperform | $281.00→ $290.00+3.2% |
|
Aug 12
00:54 UTC
|
FERG
Ferguson
|
◎ Target | John Lovallo ★★★☆☆ #1945 | Neutral | $252.00→ $256.00+1.6% |
|
Aug 12
00:54 UTC
|
FERG
Ferguson
|
◎ Target | Connor Cerniglia ★★★★☆ #836 | Outperform | $310.00→ $325.00+4.8% |
|
Aug 12
00:54 UTC
|
FERG
Ferguson
|
◎ Target | Matthew Bouley ★★★☆☆ #1118 | Overweight | $297.00→ $313.00+5.4% |
|
Aug 12
00:54 UTC
|
EWTX
Edgewise Therapeutics
|
◎ Target | Paul Choi ★★☆☆☆ #2314 | Neutral | $32.00→ $36.00+12.5% |
|
Aug 12
00:54 UTC
|
ETON
Eton Pharmaceuticals
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2798 | Buy | $57.00→ $65.00+14.0% |
|
Aug 12
00:54 UTC
|
EQH
Equitable
|
◎ Target | Ryan Krueger ★★★★★ #201 | Outperform | $62.00→ $67.00+8.1% |
|
Aug 12
00:54 UTC
|
EE
Excelerate Energy
|
◎ Target | Theresa Chen ★★★☆☆ #1443 | Overweight | $41.00→ $43.00+4.9% |
|
Aug 12
00:54 UTC
|
EBAY
eBay
|
◎ Target | Stephen Ju ★★☆☆☆ #2489 | Neutral | $107.00→ $120.00+12.1% |
|
Aug 12
00:54 UTC
|
DSP
Viant Technology
|
◎ Target | Lloyd Walmsley ★★★☆☆ #2216 | Buy | $17.00→ $19.00+11.8% |
|
Aug 12
00:54 UTC
|
DSP
Viant Technology
|
◎ Target | Barton Crockett ★★★★☆ #863 | Buy | $20.00→ $24.00+20.0% |
|
Aug 12
00:54 UTC
|
DSP
Viant Technology
|
◎ Target | Brianna Diaz not yet tracked | Market Outperform | $16.00→ $17.00+6.2% |
|
Aug 12
00:54 UTC
|
DSP
Viant Technology
|
◎ Target | Tom White ★★☆☆☆ #2562 | Buy | $16.50→ $17.50+6.1% |
|
Aug 12
00:54 UTC
|
DRTS
Alpha Tau Medical
|
◎ Target | Yi Chen ★★☆☆☆ #2429 | Buy | $15.00→ $16.00+6.7% |
|
Aug 12
00:54 UTC
|
DPRO
Draganfly
|
◎ Target | Austin Bohlig ★☆☆☆☆ #3137 | Buy | $12.00→ $8.00-33.3% |
|
Aug 12
00:54 UTC
|
DOC
Healthpeak Properties
|
◎ Target | Nick Joseph not yet tracked | Neutral | $20.00→ $22.00+10.0% |
|
Aug 12
00:54 UTC
|
DLTR
Dollar Tree
|
◎ Target | Kelly Bania ★★★☆☆ #1272 | Underperform | $90.00→ $98.00+8.9% |
|
Aug 12
00:54 UTC
|
DKNG
DraftKings
|
◎ Target | James Hardiman ★★☆☆☆ #2352 | Buy | $30.00→ $32.00+6.7% |
|
Aug 12
00:54 UTC
|
DK
Delek US
|
◎ Target | Nitin Kumar not yet tracked | Outperform | $60.00→ $66.00+10.0% |
|
Aug 12
00:54 UTC
|
DHT.UN
DRI Healthcare Trust
|
◎ Target | firm only | Buy | C$25.00→ C$26.00+4.0% |
|
Aug 12
00:54 UTC
|
DH
Definitive Healthcare
|
◎ Target | Craig Hettenbach ★★★★★ #292 | Equal Weight | $2.50→ $1.50-40.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.